Scientific and Medical Equipment House Company
4014.SRSAUHealthcare● Active
$31.50
$-0.10(-0.32%)
Market Cap$945000000
P/E Ratio—
52W High$41
52W Low$26
Scientific and Medical Equipment House Company (4014.SR) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
4014.SR · earnings · updated Jun 15, 2026
Latest Earnings
Q1 FY2026Report Date: Mar 9, 2026EPS Actual
$0.02
Revenue
$0.18B
Fiscal Period
Q1 FY2026
FY ends December
Report Date
Mar 9, 2026
After Market Close
4014.SR reports quarterly as a SAU-listed Medical - Instruments & Supplies company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
79
days
Expected Date
Sep 2, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Days Away79
Expected DateSep 2, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| — Q1 FY2026 | Mar 9, 2026 | — | $0.02 | — | $0.18B | — | — |
| — Q4 FY2025 | Nov 5, 2025 | — | $0.26 | — | $0.20B | — | — |
| — Q3 FY2025 | Aug 10, 2025 | — | $0.41 | — | $0.27B | $0.22B | +21.4% |
| — Q2 FY2025 | May 12, 2025 | — | $0.26 | — | $0.22B | $0.23B | -3.2% |
| — Q1 FY2025 | Mar 25, 2025 | — | -$0.12 | — | $0.23B | $0.24B | -6.1% |
| — Q4 FY2024 | Nov 7, 2024 | — | $0.36 | — | $0.22B | $0.27B | -17.6% |
| — Q3 FY2024 | Aug 7, 2024 | — | $0.26 | — | $0.22B | $0.24B | -8.9% |
| — Q2 FY2024 | May 17, 2024 | — | $0.29 | — | $0.22B | $0.23B | -5.7% |
Q1 FY2026
Mar 9, 2026
EPS Actual
$0.02
EPS Est.
—
EPS Surpr.
—
Revenue
$0.18B
Q4 FY2025
Nov 5, 2025
EPS Actual
$0.26
EPS Est.
—
EPS Surpr.
—
Revenue
$0.20B
Q3 FY2025
Aug 10, 2025
EPS Actual
$0.41
EPS Est.
—
EPS Surpr.
—
Revenue
$0.27B
Q2 FY2025
May 12, 2025
EPS Actual
$0.26
EPS Est.
—
EPS Surpr.
—
Revenue
$0.22B
Q1 FY2025
Mar 25, 2025
EPS Actual
-$0.12
EPS Est.
—
EPS Surpr.
—
Revenue
$0.23B
Q4 FY2024
Nov 7, 2024
EPS Actual
$0.36
EPS Est.
—
EPS Surpr.
—
Revenue
$0.22B
Q3 FY2024
Aug 7, 2024
EPS Actual
$0.26
EPS Est.
—
EPS Surpr.
—
Revenue
$0.22B
Q2 FY2024
May 17, 2024
EPS Actual
$0.29
EPS Est.
—
EPS Surpr.
—
Revenue
$0.22B
Analyst Estimates
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2028 | $0.00 | $0.00 | $0.00 | 0 |
| Q3 FY2028 | $0.00 | $0.00 | $0.00 | 0 |
| Q2 FY2028 | $0.00 | $0.00 | $0.00 | 0 |
| Q1 FY2028 | $0.00 | $0.00 | $0.00 | 0 |
| Q4 FY2027 | $0.00 | $0.00 | $0.00 | 0 |
| Q3 FY2027 | $0.00 | $0.00 | $0.00 | 0 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2028 | $0.2B | $0.2B | $0.2B | 1 |
| Q3 FY2028 | $0.2B | $0.2B | $0.2B | 1 |
| Q2 FY2028 | $0.2B | $0.2B | $0.2B | 1 |
| Q1 FY2028 | $0.3B | $0.3B | $0.3B | 1 |
| Q4 FY2027 | $0.2B | $0.2B | $0.2B | 1 |
| Q3 FY2027 | $0.2B | $0.2B | $0.2B | 1 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| — Q1 FY2026 | Mar 9, 2026 | — | $28.72 | $29.10 | +1.32% |
| — Q4 FY2025 | Nov 5, 2025 | — | $38.34 | $36.88 | -3.81% |
| — Q3 FY2025 | Aug 10, 2025 | — | $35.86 | $36.38 | +1.45% |
| — Q2 FY2025 | May 12, 2025 | — | $39.60 | $40.60 | +2.53% |
| — Q1 FY2025 | Mar 25, 2025 | — | $42.95 | $41.00 | -4.54% |
| — Q4 FY2024 | Nov 7, 2024 | — | $55.30 | $54.90 | -0.72% |
| — Q3 FY2024 | Aug 7, 2024 | — | $54.00 | $53.80 | -0.37% |
| — Q2 FY2024 | May 17, 2024 | — | $50.10 | $48.15 | -3.89% |
Q1 FY2026+1.32%
Report Date
Mar 9, 2026
EPS Beat/Miss
—
Price Before
$28.72
Price After
$29.10
Q4 FY2025-3.81%
Report Date
Nov 5, 2025
EPS Beat/Miss
—
Price Before
$38.34
Price After
$36.88
Q3 FY2025+1.45%
Report Date
Aug 10, 2025
EPS Beat/Miss
—
Price Before
$35.86
Price After
$36.38
Q2 FY2025+2.53%
Report Date
May 12, 2025
EPS Beat/Miss
—
Price Before
$39.60
Price After
$40.60
Q1 FY2025-4.54%
Report Date
Mar 25, 2025
EPS Beat/Miss
—
Price Before
$42.95
Price After
$41.00
Q4 FY2024-0.72%
Report Date
Nov 7, 2024
EPS Beat/Miss
—
Price Before
$55.30
Price After
$54.90
Q3 FY2024-0.37%
Report Date
Aug 7, 2024
EPS Beat/Miss
—
Price Before
$54.00
Price After
$53.80
Q2 FY2024-3.89%
Report Date
May 17, 2024
EPS Beat/Miss
—
Price Before
$50.10
Price After
$48.15
Beat Rate0 / 8 quarters
Largest Move-4.54% (Q1 FY2025)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: 4014.SR ends December
Scientific and Medical Equipment House Company (4014.SR) most recently reported earnings on March 9, 2026 for Q1 FY2026, posting EPS of $0.02 (in line with the analyst consensus of —). The next 4014.SR earnings date is expected around September 2, 2026.
Each quarter, investors track 4014.SR earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. 4014.SR revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
4014.SR's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
4014.SR earnings · 4 questionsScientific and Medical Equipment House Company's next earnings report is expected around September 2, 2026. 4014.SR typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; 4014.SR historically reports after market close (AMC).
4014.SR earnings datewhen is 4014.SR earnings4014.SR next earnings datewhen does 4014.SR report earnings4014.SR earnings calendar
▸ Source: FMP · Scientific and Medical Equipment House Company SEC filings · US GAAP · Scientific and Medical Equipment House Company SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 15, 2026